Tim Sandle explores the main factors that influence particle accumulation in pharmaceutical cleanrooms, advising how best to control risks and minimise operator contamination.
The German Pharmaceutical Industry Association has launched the ERA Pooling Initiative, a collaborative project enabling marketing authorisation holders to share environmental data, reduce duplicative testing and meet tightening regulatory requirements.
A hybrid model built into commercial software and running a self-driving bioreactor has found that unmeasured cellular waste, not the usual metabolites, throttles perfusion yields.
The definitive guide to transitioning from manual, offline batch testing to automated, continuous biomanufacturing.
German biotech’s incoming leader set ahead of its goal of having multiple approved products by 2030.
United Nations agency calls for coordinated action across the pharmaceutical value chain to align with existing regulatory practices that aid sustainable medicine innovation.
A new analytical approach combining terahertz spectroscopy with machine learning could support faster, non-destructive monitoring of active pharmaceutical ingredient content.
In vivo-focused collaboration has scope to considerably boost therapeutic innovation and address unmet need in immune-mediated diseases.
Join this webinar to discover how UV-Vis spectroscopy and gas chromatography support API monitoring, testing and analysis.
EPR’s 2026 nitrosamines report covers the key developments in manufacturing, quality, regulation, analytical development and beyond.
With the EU’s pharmaceutical legislation reform soon to come into force, regulatory experts outline what is changing across both US and European frameworks and how sponsors can position pipelines ahead of implementation.
Manual sampling cycles leave bioreactor control decisions hours behind culture dynamics. Process Raman spectroscopy offers continuous, real-time measurement of critical parameters, enabling true closed-loop control in perfusion and continuous bioprocessing applications where measurement lag directly impacts yield and product quality.
The biopharmaceutical industry has embraced Pharma 4.0 concepts, but the measurement infrastructure required to realise autonomous facilities and continuous bioprocessing remains underdeveloped. Process Raman spectroscopy offers continuous, non-destructive monitoring at frequencies aligned with cell culture dynamics, bridging the gap between control system capabilities and available data.